Psychotropic medication use in pediatric patients with cancer.

Full Abstract

BACKGROUND:
Use of psychotropic medication in medically ill adults, in particular, patients with cancer, is common. While increased use of psychotropic medications in children and adolescents in the general population has been reported, little is known about the prescribing practices for these medications in medically ill children.

OBJECTIVE:
To examine the frequency and types of psychotropic medications used in a population of children and adolescents with cancer.

DESIGN:
Retrospective review of the National Institutes of Health Medical Information System.

SETTING:
Pediatric Oncology Branch of the National Cancer Institute, National Institutes of Health.

PARTICIPANTS:
Three hundred forty-seven patients aged 1 to 21 years who were enrolled in clinical research trials at the Pediatric Oncology Branch between January 2000 and December 2003.

MAIN OUTCOME MEASURES:
Psychotropic medication use was analyzed according to cancer diagnosis and patient age.

RESULTS:
Fourteen percent of identified patients had been prescribed at least 1 psychotropic medication at the time of National Cancer Institute clinical trial enrollment. The most commonly used medications were anticonvulsant agents (8%) and antidepressant medications (7%), in particular, selective serotonin reuptake inhibitors. Anxiolytic medications could not be accurately assessed because of their frequent use as antiemetic agents in many chemotherapy regimens. Psychostimulant use was rare.

CONCLUSIONS:
This study suggests that psychotropic medications are commonly prescribed to children and adolescents with cancer. Clinical safety and efficacy trials are needed in medically ill children at high risk for mood and anxiety symptoms.

Learn Faster Today Improve your study skills

Author information

Author/s: Pao, Maryland (M); Ballard, Elizabeth D (ED); Rosenstein, Donald L (DL); Wiener, Lori (L); Wayne, Alan S (AS);

Affiliation: Office of the Clinical Director, National Institute of Mental Health, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Md. 20892, USA.

Journal and publication information

Publication Type: Journal Article; Research Support, N.I.H., Intramural

Journal: Archives of pediatrics & adolescent medicine (Arch Pediatr Adolesc Med), published in United States. (Language: eng)

Reference: 2006-Aug; vol 160 (issue 8) : pp 818-22

Dates: Created 2006/08/08; Completed 2006/08/24; Revised 2006/11/15;

PMID: 16894081, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Infant
Male
Mental Disorders - drug therapy; etiology
Neoplasms - complications; psychology
Physician's Practice Patterns
Psychotropic Drugs - therapeutic use
Retrospective Studies

Associated Chemicals: Psychotropic Drugs (0)

These are the highest related articles currently in the database:

See 100+ related articles.